UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$589.14 USD
-5.18 (-0.87%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $589.50 +0.36 (0.06%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$589.14 USD
-5.18 (-0.87%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $589.50 +0.36 (0.06%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum C VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
3 Great Compounder Stocks to Buy for Strong Returns in All Environments
by Ethan Feller
Compounder stocks are companies that can deliver sustainable long term growth across different types of economic environments
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QUS
Stock Market News for Feb 3, 2023
by Zacks Equity Research
Wall Street closed mixed on Thursday after a choppy session.
Humana (HUM) Q4 Earnings Beat Mark, '23 EPS View Upbeat
by Zacks Equity Research
Humana's (HUM) fourth-quarter results benefit from solid premiums from its individual Medicare Advantage business and the sound performance of the two newly formed segments.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
HCA Healthcare (HCA) Q4 Earnings Lag on High Costs, Hikes Dividend
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results suffer a blow from added expenses incurred due to Hurricane Ian. Increased patient admissions partly offset the downside.
Elevance Health (ELV) Tops on Q4 Earnings, Hikes Dividend
by Zacks Equity Research
Elevance Health's (ELV) fourth-quarter earnings gain on solid premiums from its Medicaid business. Management approves a quarterly dividend hike of 16%.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
3 Ultra-Cheap Value ETFs for Long-Term Investors
by Neena Mishra
Can value continue to outperform growth?
Is Most-Watched Stock UnitedHealth Group Incorporated (UNH) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Analyst Blog Highlights UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy
by Zacks Equity Research
UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy are part of the Zacks top analyst blog.
Top Research Reports for UnitedHealth Group, Coca-Cola & Roche Holding
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Coca-Cola Company (KO) and Roche Holding AG (RHHBY).
UnitedHealth Beats Q4 Earnings: ETFs in Focus
by Sweta Killa
UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate for earnings.
UnitedHealth (UNH) Beats on Q4 Earnings, Retains 2023 View
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results gain from sustained membership growth in its UnitedHealthcare business.
UnitedHealth Group (UNH) Tops Q4 Earnings Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.29% and 0%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA
UnitedHealth (UNH) Unit Ties Up to Boost Care in Two U.S. Regions
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum aims to advance organizational efficiencies of Owensboro Health and bring about better health outcomes in western Kentucky and southern Indiana.
3 High-Quality Dividend ETFs for 2023
by Neena Mishra
We highlight 3 ultra-cheap ETFs that focus on quality & sustainability of dividends
UnitedHealth's (UNH) UnitedHealthcare Unit to Aid Q4 Earnings?
by Zacks Equity Research
An increase in the number of people served in the commercial domestic business of UnitedHealth's (UNH) UnitedHealthcare segment is likely to boost fourth-quarter results.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Should Vanguard Mega Cap Value ETF (MGV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MGV
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV